Cargando...
Use of synthetic adrenocorticotropic hormone in patients with IgA nephropathy
BACKGROUND: Synthetic adrenocorticotropic hormone (ACTH) has been demonstrated to be effective in patients with membranous nephropathy, minimal change disease and some histological subtypes of focal segmental glomerulosclerosis. Its clinical impact in patients with IgA nephropathy is currently uncle...
Gardado en:
| Publicado en: | BMC Nephrol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5966849/ https://ncbi.nlm.nih.gov/pubmed/29792169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-0915-4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|